| Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ... Alzheimer's & Dementia 16 (1), 106-117, 2020 | 94 | 2020 |
| A brain capital grand strategy: toward economic reimagination E Smith, D Ali, B Wilkerson, WD Dawson, K Sobowale, C Reynolds, ... Molecular psychiatry 26 (1), 3-22, 2021 | 60 | 2021 |
| Use of the CDR® plus NACC FTLD in mild FTLD: data from the ARTFL/LEFFTDS consortium T Miyagawa, D Brushaber, J Syrjanen, W Kremers, J Fields, LK Forsberg, ... Alzheimer's & Dementia 16 (1), 79-90, 2020 | 57 | 2020 |
| Current directions in tau research: Highlights from Tau 2020 C Sexton, H Snyder, D Beher, AL Boxer, P Brannelly, JP Brion, L Buée, ... Alzheimer's & Dementia 18 (5), 988-1007, 2022 | 53 | 2022 |
| Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases EM Ramos, DR Dokuru, V Van Berlo, K Wojta, Q Wang, AY Huang, ... Alzheimer's & Dementia 16 (1), 118-130, 2020 | 52 | 2020 |
| The longitudinal evaluation of familial frontotemporal dementia subjects protocol: framework and methodology B Boeve, J Bove, P Brannelly, D Brushaber, G Coppola, R Dever, C Dheel, ... Alzheimer's & Dementia, 2019 | 43 | 2019 |
| Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration AM Staffaroni, Y Cobigo, SYM Goh, J Kornak, L Bajorek, K Chiang, ... Alzheimer's & Dementia 16 (1), 37-48, 2020 | 40 | 2020 |
| Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: nIH‐EXAMINER as a potential clinical trial endpoint AM Staffaroni, L Bajorek, KB Casaletto, Y Cobigo, SYM Goh, A Wolf, ... Alzheimer's & Dementia 16 (1), 11-21, 2020 | 37 | 2020 |
| Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration NT Olney, E Ong, SYM Goh, L Bajorek, R Dever, AM Staffaroni, Y Cobigo, ... Alzheimer's & Dementia 16 (1), 49-59, 2020 | 34 | 2020 |
| Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort HW Heuer, P Wang, K Rascovsky, A Wolf, B Appleby, J Bove, Y Bordelon, ... Alzheimer's & Dementia 16 (1), 60-70, 2020 | 30 | 2020 |
| Nonlinear Z‐score modeling for improved detection of cognitive abnormality J Kornak, J Fields, W Kremers, S Farmer, HW Heuer, L Forsberg, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 11 (1 …, 2019 | 20 | 2019 |
| Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers Q Chen, BF Boeve, CG Schwarz, R Reid, N Tosakulwong, TG Lesnick, ... Neurobiology of aging 83, 54-62, 2019 | 16 | 2019 |
| Building brain capital HA Eyre, R Ayadi, W Ellsworth, G Aragam, E Smith, WD Dawson, ... Neuron 109 (9), 1430-1432, 2021 | 11 | 2021 |
| Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort MT Gentry, MI Lapid, J Syrjanen, K Calvert, S Hughes, D Brushaber, ... Alzheimer's & Dementia 16 (8), 1115-1124, 2020 | 11 | 2020 |
| Investing in late-life brain capital WD Dawson, E Smith, L Booi, M Mosse, H Lavretsky, CF Reynolds III, ... Innovation in aging 6 (3), igac016, 2022 | 10 | 2022 |
| Analysis of tauopathy research funding between 2006 and 2016 reveals critical gaps in research priorities CM Altimus, K Keller, P Brannelly, E Ross, CT Lin, EAU Riley, LT Briggs, ... Alzheimer's & Dementia 15 (1), 42-54, 2019 | 3 | 2019 |
